<unk> (oral) is an antiviral that is FDA approved for the prevention of CMV disease in solid organ transplant recipients and in individuals with advanced HIV infection at risk for developing CMV disease.   Common adverse reactions include pruritus, sweating, diarrhea, loss of appetite, vomiting, anemia, neutropenia, thrombocytopenia, neuropathy, blurred vision,punctate keratitis, vitreous hemorrhage.
Ganciclovir 
Valganciclovir hydrochloride
Valacyclovir
Acyclovir 
Penciclovir
Tenofovir
Letermovir
Cidofovir